Remdesivir ‘Disastrous’ as COVID Treatment, But Government Pays Hospitals to Use It
Remdesivir, the primary COVID-19 drug approved for use in U.S. hospitals, routinely causes severe organ damage and, often, death, but U.S. government pays hospitals a 20% upcharge, plus an additional bonus, for using the remdesivir protocol.
“Those who are able to see beyond the shadows and lies of their culture will never be understood, let alone believed, by the masses.” - Plato
Seeking Truth in a World of Propaganda. Links do not necessarily indicate agreement with stories or perspectives.